These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2891337)

  • 1. HLA-DQ restriction fragment length polymorphisms in myasthenia gravis.
    Bell JI; Steinman L; Toyka K; McDevitt HO
    Ann N Y Acad Sci; 1987; 505():382-7. PubMed ID: 2891337
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular probing of disease susceptibility genes in myasthenia gravis patients: an analysis of T-cell receptor and HLA class II genes using restriction fragment length polymorphism.
    Smith CI; Borgonovo L; Carlsson B; Hammarström L; Rabbitts TH
    Ann N Y Acad Sci; 1987; 505():388-97. PubMed ID: 3120635
    [No Abstract]   [Full Text] [Related]  

  • 3. [HLA-DQ molecules associated with myasthenia gravis in Chinese patients].
    Li X; Zhang KX; Fan YX; Chen XZ; Zuo J; Pan XH; Zhu DL; Geng ZC
    Yi Chuan Xue Bao; 1999; 26(4):295-300. PubMed ID: 10593018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA polymorphism of the class II genes in DR4 cells.
    So A; Bodmer J
    Dis Markers; 1986 Jun; 4(1-2):165-72. PubMed ID: 2898313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
    Yousefipour GA; Salami Z; Farjadian S
    Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific allelic variation among linked HLA class II genes.
    Amar A; Holbeck SL; Nepom GT
    Transplantation; 1987 Dec; 44(6):831-5. PubMed ID: 2892292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DQ polymorphism analyzed by sequential restriction endonuclease DNA digestion.
    Trucco M; Rosenshine S; Cascino I; Duquesnoy RJ
    Immunogenetics; 1986; 24(3):184-90. PubMed ID: 2875943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.
    Raju R; Zhan WZ; Karachunski P; Conti-Fine B; Sieck GC; David C
    J Immunol; 1998 May; 160(9):4169-74. PubMed ID: 9574516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region.
    Szafer F; Brautbar C; Tzfoni E; Frankel G; Sherman L; Cohen I; Hacham-Zadeh S; Aberer W; Tappeiner G; Holubar K
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6542-5. PubMed ID: 2888115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis with thymic hyperplasia is associated with polymorphisms in the tumor necrosis factor region.
    Hjelmström P; Peacock CS; Giscombe R; Pirskanen R; Lefvert AK; Blackwell JM; Sanjeevi CB
    Ann N Y Acad Sci; 1998 May; 841():368-70. PubMed ID: 9668261
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between DQ alpha and DQ beta RFLP and cell surface polymorphisms of class II HLA antigens.
    Cascino I; Rosenshine S; Turco E; Marrari M; Duquesnoy RJ; Trucco M
    J Immunogenet; 1986; 13(5-6):387-400. PubMed ID: 2887620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis.
    Carlsson B; Wallin J; Pirskanen R; Matell G; Smith CI
    Immunogenetics; 1990; 31(5-6):285-90. PubMed ID: 1973409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction fragment length polymorphism in Felty's syndrome.
    Sansom DM; Bidwell JL; Klouda PT; Maddison PJ
    Dis Markers; 1986 Jun; 4(1-2):185-9. PubMed ID: 2898315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis is associated with two DQ alpha/beta heterodimers.
    Khalil I; Berrih-Aknin S; Lepage V; Lost MN; Gajdos P; Charron D; Hors J; Degos L
    Ann N Y Acad Sci; 1993 Jun; 681():573-4. PubMed ID: 8357201
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis.
    Hjelmström P; Giscombe R; Lefvert AK; Pirskanen R; Kockum I; Landin-Olsson M; Sanjeevi CB
    J Neuroimmunol; 1996 Apr; 65(2):125-31. PubMed ID: 8964894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular aspects of HLA class II and some autoimmune diseases.
    Lepage V; Lamm LU; Charron D
    Eur J Immunogenet; 1993 Jun; 20(3):153-64. PubMed ID: 8338813
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA-DR, DQ, and DX alpha RFLPs and their associations with serologically defined HLA-DR and -DQ antigens.
    Awad J; Navarrete C; Sachs JA; Festenstein H; Cassell PG; Niven MJ; Hitman G
    Immunogenetics; 1988; 27(1):73-6. PubMed ID: 2890578
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of HLA-DR/DQ polymorphism with myasthenia gravis in Tunisian patients.
    Fekih-Mrissa N; Klai S; Zaouali J; Gritli N; Mrissa R
    Clin Neurol Neurosurg; 2013 Jan; 115(1):32-6. PubMed ID: 22521184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
    Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
    Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
    Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
    J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.